Teikyo University Hospital
Itabashi-ku, Tokyo 1738606
3 studies enrolling now · 20 studies all time
What they study most
ALS, Alopecia Areata, Asthma, Atherosclerotic Cardiovascular Disease, Atopic Dermatitis, Coronary Arteriosclerosis, Coronary Artery Disease, Non ST Segment Elevation Acute Coronary Syndrome, Obesity, Overweight, Plaque Psoriasis, Polycystic Kidney Disease, Autosomal Dominant
Studies at this site
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
- Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib — Recruiting now
- A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis — Recruiting now
- A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) — Completed
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
- A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) — Stopped early
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma — Completed
- Registry of Asthma Patients Initiating DUPIXENT® — Completed
- Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS — Stopped early
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment — Completed
- A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
- Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis — Completed
- Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
- HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt — Completed
- A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis — Completed
- A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
- EVOLVE Short DAPT Study — Completed
- The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions — Completed
- Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Completed